AI-powered device to help treat diabetes patients unveiled by medtech firm

The product is designed to accelerate wound healing and lower the risk of amputations
Assessment
The unveiling of an AI-powered device specifically targeting wound healing and amputation risk in diabetes patients signals a shift toward tech-driven diabetic care. If effective, this could reduce severe complications and lower healthcare burdens. The next step is to watch for clinical trial data and regulatory approvals that determine real-world adoption.

